Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Tubular Breast Cancer Stage II|Mucinous Breast Cancer Stage II|Breast Cancer Female NOS|Invasive Ductal Breast Cancer|Tubular Breast Cancer Stage III|HER-2 Positive Breast Cancer|Inflammatory Breast Cancer Stage IV|Inflammatory Breast Cancer
Interventions: DRUG: nab-Paclitaxel|DRUG: Paclitaxel
Sponsor: German Breast Group
Collaborators: Celgene Corporation|Roche Pharma AG